Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI

NCT03406819 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

ST Segment Elevation Myocardial Infarction
Primary Percutaneous Coronary Intervention

Interventions

DRUG: Nitroprusside Sodium
DRUG: Tirofiban Hydrochloride
DRUG: Heparinized saline

Sponsor

The First Affiliated Hospital of Zhengzhou University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]